The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
ALMS
Alumis: director buys $10 million after a plunge
A fund managed by an Alumis director purchased shares worth $10.7 million, just three days after the stock lost more than half its value following a failed clinical trial.
Other Stories
Unusual insider buying alert!
PremiumInsidersAMRC2h ago2 min read
Fund manager sold $5.9 million in shares and returned to buy at a third of the price
PremiumInsidersLMB3h ago2 min read
Is Adobe on the path to destruction?
DeepdivesADBE4h ago3 min read